The Thread Formerly Known as No Rest For The Wicked Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Thread Formerly Known as No Rest For The Wicked

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Junkyardawg who wrote (8028)	1/16/1999 10:50:00 PM
From: Junkyardawg	Read Replies (1) of 90042

DD: Sub $5 stock. Ticker: "HIV" 52wk low $1 1/2 52wk high $6 1/2 Business Summary Cel-Sci Corporation is involved in the research and development of certain drugs and vaccines using the Company's proprietary cell culture technologies. HIV's first product, MULTIKINE, is being tested to determine if it is effective in improving the immune response of cancer patients. For the nine months ended 6/30/98, total income rose 28% to $483 thousand. Net loss fell 31% to $4.5 million. Results reflect higher interest income and the absence of license acquisition costs. Mkt Cap: $25.2 mm Shrs Out: 11.5 mm Float: 10.6 mm 3-Mth Ave Vol: 118 k 10-Day Ave Vol: 431 k Short Int: 0.4 mm Inst Own: 1.1 % Insider Own: 8.0 % P/E (ttm): -2.9 News: biz.yahoo.com dawg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next